ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625857 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625857; 2) Community: the network communities that were significantly associated with the response to NSC 625857; 3) Molecule: the relationships between components within communities and NSC 625857; 4) MDR: the compounds that were significantly associated with the NSC 625857.

NSC Compound Enrichment Correlation
NSC 381864 PICEATANNOL, 4,3',5'-TRIMETHYL,1S0 0.00010455364200097 0.55933432
NSC 686560 [Di-17.alpha./.beta.-(2-ethoxy-3-hydroxyestra-1,3,5(10)-triene)-]sulphite 0.000260156221906648 0.55400437
NSC 58574 Pyrimidine, 2,4,5-trichloro-6-propyl- 0.000294004970380715 0.48809906
NSC 683289 Null 0.000294004970380715 0.27748859
NSC 95466 PCNU 0.000294004970380715 0.39694503
NSC 720702 Null 0.000345299270690661 0.41045353
NSC 119875 Cisplatin 0.000497857311992526 0.52817907
NSC 673499 Null 0.000584785790823226 0.56384422
NSC 682429 2-(1-Propynyl)-3,17.beta.-estradiol 0.000706163530262832 0.51012562
NSC 723888 3-benzyl-2-methyl-4,5-dioxo-4,5-dihydro-3H-benzo[e]indole-1-carboxylic acid, ethyl ester 0.000751340623722758 0.43646292
Total:51  Current:1    [First] [Prev] [Next] [Last]